Evidence map›Paper›PMID 29763554›Full record

ArticleBioconjugate chemistry2018

Template-Catalyzed, Disulfide Conjugation of Monoclonal Antibodies Using a Natural Amino Acid Tag.

Jeremy D King, Yuelong Ma, Yi-Chiu Kuo, Krzysztof P Bzymek, Leah H Goodstein, Kassondra Meyer, Roger E Moore, Desiree Crow, David M Colcher, Gagandeep Singh and 2 more

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jeremy D King
Yuelong Ma
Yi-Chiu Kuo
Krzysztof P Bzymek
Leah H Goodstein
Kassondra Meyer
Roger E Moore
Desiree Crow
David M Colcher
Gagandeep Singh
David A Horne
City of Hope · USCity Of Hope National Medical Center · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
In situ Imaging of CAR T-cellsR21CA193055 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI BROWN, CHRISTINE, WILLIAMS, JOHN CHARLES · 2015 to 2017
$740k
Monoclonal Antibody-based Prodrugs - Novel Tools for Cancer TherapyR21CA135216 · NCI · THOMAS JEFFERSON UNIVERSITY · PI RODECK, ULRICH, WILLIAMS, JOHN CHARLES · 2010 to 2011
$392k
NCI NIH HHS P30 CA033572NCI NIH HHS R21 CA135216NCI NIH HHS R21 CA193055
6 · The paper itself

Abstract

The high specificity and favorable pharmacological properties of monoclonal antibodies (mAbs) have prompted significant interest in re-engineering this class of molecules to add novel functionalities for enhanced therapeutic and diagnostic potential. Here, we used the high affinity, meditope-Fab interaction to template and drive the rapid, efficient, and stable site-specific formation of a disulfide bond. We demonstrate that this template-catalyzed strategy provides a consistent and reproducible means to conjugate fluorescent dyes, cytotoxins, or "click" chemistry handles to meditope-enabled mAbs (memAbs) and memFabs. More importantly, we demonstrate this covalent functionalization is achievable using natural amino acids only, opening up the opportunity to genetically encode cysteine meditope "tags" to biologics. As proof of principle, genetically encoded, cysteine meditope tags were added to the N- and/or C-termini of fluorescent proteins, nanobodies, and affibodies, each expressed in bacteria, purified to homogeneity, and efficiently conjugated to different memAbs and meFabs. We further show that multiple T-cell and Her2-targeting bispecific molecules using this strategy potently activate T-cell signaling pathways in vitro. Finally, the resulting products are highly stable as evidenced by serum stability assays (>14 d at 37 °C) and in vivo imaging of tumor xenographs. Collectively, the platform offers the opportunity to build and exchange an array of functional moieties, including protein biologics, among any cysteine memAb or Fab to rapidly create, test, and optimize stable, multifunctional biologics.

Indexed as

Amino AcidsAnimalsAntibodies, MonoclonalBreast NeoplasmsCatalysisClick ChemistryDisulfidesFemaleFluorescent DyesHumansImmunoconjugatesImmunoglobulin Fab FragmentsMCF-7 CellsMiceModels, MolecularOptical ImagingAmino AcidsAntibodies, MonoclonalDisulfidesFluorescent DyesImmunoconjugatesImmunoglobulin Fab FragmentsTrastuzumab

Identifiers

PMID29763554
PMCPMC6823927
OpenAlexW2804588762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.